Table of Content

Scope and Methodology
1.1. Research Methodology
1.2. Scope of the Market

2. Key Trends and Developments

3. Executive Summary
3.1. Market Snippet by Diagnostics
3.2. Market Snippet by Therapeutics
3.3. Market Snippet by Sales Channel
3.4. Market Snippet by Region

4. Market Dynamics
4.1. Market impacting factors
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Impact analysis

5. Industry Analysis
5.1. Porter’s five forces analysis
5.2. Value chain analysis
5.3. Patent Analysis
5.4. Regulatory Analysis

6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives

7. By Diagnostics
7.1. Introduction
7.1.1. Market size analysis, and y-o-y growth analysis (%), By Diagnostics
Segment
7.1.2. Market attractiveness index, By Diagnostics Segment
7.2. Imaging Techniques *
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
7.3. Diagnostic Tests
7.4. Biopsy

8. By Therapeutics
8.1. Introduction
8.1.1. Market size analysis, and y-o-y growth analysis (%), By Therapeutics Segment
8.1.2. Market attractiveness index, By Therapeutics Segment
8.2. Ocaliva *
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
8.3. Elafibranor
8.4. Cenicriviroc
8.5. Selonsertib
8.6. Others

9. By Sales Channel
9.1. Introduction
9.1.1. Market size analysis, and y-o-y growth analysis (%), By Sales Channel Segment
9.1.2. Market attractiveness index, By Sales Channel Segment
9.2. Hospital Pharmacy *
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2020-2029 And Y-O-Y Growth Analysis (%), 2021-2029
9.3. Online Channel
9.4. Retail Channel

10. By Region
10.1. Introduction
10.1.1. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key region-specific dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostics
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
10.2.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. South America
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostics
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
10.3.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.3.6.1. Brazil
10.3.6.2. Argentina
10.3.6.3. Rest of South America
10.4. Europe
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostics
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
10.4.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.4.6.1. Germany
10.4.6.2. U.K.
10.4.6.3. France
10.4.6.4. Spain
10.4.6.5. Italy
10.4.6.6. Rest of Europe
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostics
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel
10.5.6. Market Size Analysis, And Y-O-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Diagnostics
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutics
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Sales Channel

11. Competitive Landscape
11.1. Competitive scenario
11.2. Competitor strategy analysis
11.3. Market positioning/share analysis
11.4. Mergers and acquisitions analysis

12. Company Profiles
12.1. Abbvie Inc. *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Cadila Healthcare Limited
12.3. Conatus Pharmaceuticals Inc.
12.4. Exalenz Bioscience Ltd.
12.5. Genfit SA
12.6. Gilead Sciences Inc.
12.7. Intercept Pharmaceuticals Inc.
12.8. Merck & Co., Inc.
12.9. Novartis AG
12.10. Novo Nordisk A/S
12.11. Quest Diagnostics
12.12. Shire Plc
12.13. Siemens Healthineers
12.14. Thermo Fisher Scientific Inc.
12.15. WuXi AppTec
*List not Exhaustive*

13. DataM
13.1. Appendix
13.2. About us and services
13.3. Contact us